DOCSLIB.ORG

Memory-Like CD8 and CD4 T Cells Cooperate to Break Peripheral

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Memory-Like CD8 and CD4 T Cells Cooperate to Break Peripheral Memory-like CD8؉ and CD4؉ T cells cooperate to break peripheral tolerance under lymphopenic conditions Cecile Le Saout, Sandie Mennechet, Naomi Taylor, and Javier Hernandez1 Institut de Ge´ne´ tique Mole´culaire de Montpellier Unite´Mixte de Recherche 5535, Centre National de la Recherche Scientifique, Université de Montpellier 1 and 2, 34293 Montpellier, Cedex 5, France Edited by N. Avrion Mitchison, University College London, London, United Kingdom, and approved October 20, 2008 (received for review August 10, 2008) The onset of autoimmunity in experimental rodent models and established (9). In the case of naive T cells, T cell antigen receptor patients frequently correlates with a lymphopenic state. In this (TCR) interactions with MHC/self-peptide complexes (those that condition, the immune system has evolved compensatory homeo- mediate positive selection) and the IL-7 cytokine appear to be static mechanisms that induce quiescent naive T cells to proliferate required for this expansion (10–15). Recently, an IL-7 independent and differentiate into memory-like lymphocytes even in the apparent form of lymphopenia-driven proliferation has also been described absence of antigenic stimulation. Because memory T cells have less (16). However, in all these cases, proliferating cells differentiate and stringent requirements for activation than naive cells, we hypothe- acquire a memory-like phenotype and the ability to rapidly secrete sized that autoreactive T cells that arrive to secondary lymphoid effector cytokines (12, 17–19). Although memory-like T cells have organs in a lymphopenic environment could differentiate and bypass never been activated by cognate antigen, do not pass through an the mechanisms of peripheral tolerance such as those mediated by effector phase, and, as such, cannot be considered to be ‘‘true’’ self-antigen cross-presentation. Here, we show that lymphopenia- memory cells, recent reports demonstrate that they are functionally driven proliferation and differentiation of potentially autoreactive indistinguishable from memory cells (20). Therefore, it has been -CD8؉ T cells into memory-like cells is not sufficient to induce self- hypothesized that the proliferation and differentiation of poten reactivity against a pancreatic antigen. Induction of an organ-specific tially autoreactive T cells may result in the induction of autoim- .autoimmunity required antigen-specific CD4؉ T cell help. Notably, we munity in a lymphopenic environment (21). Indeed, the group of N (found that this function could be accomplished by memory-like CD4؉ Sarvetnik elegantly demonstrated that nonobese diabetic (NOD T cells generated in vivo through lymphopenia-induced proliferation. mice are mildly lymphopenic and that there is a strong correlation These helper cells promoted the further differentiation of memory- between lymphopenia-induced proliferation of autoreactive T cells ؉ like CD8 T cells into effectors in response to antigen cross-presen- and the onset of diabetes (22). Autoreactive CD8ϩ and CD4ϩ T tation, resulting in their migration to the tissue of antigen expression cells displayed a memory phenotype, with CD8ϩ T cells having a where autoimmunity ensued. Thus, the cooperation of self-reactive major role in the pathogenesis of the disease (22). ؉ ؉ memory-like CD4 and CD8 T cells under lymphopenic conditions The ensemble of these observations points to lymphopenia as a overcomes cross-tolerance resulting in autoimmunity. trigger of autoimmunity and to memory-like T cells, generated through homeostatic mechanisms, as pathogenic effectors. How- autoimmunity ͉ T cell help ͉ T cell homeostasis ever, in complex models such as NOD mice, multiple genetic and environmental factors contribute to disease. Therefore, it is not utoimmunity has been paradoxically associated with lym- known whether potentially autoreactive memory-like T cells are in Aphopenia, a state in which reduced numbers of circulating themselves sufficient to induce organ-specific autoimmunity under lymphocytes are present, in a number of experimental rodent lymphopenic conditions and whether CD8ϩ and CD4ϩ T cells models and patients (1, 2). In humans, the association of T cell cooperate in this task. Also, the mechanisms by means of which lymphopenia with autoimmunity has been described in patients lymphopenia-induced proliferation and differentiation of poten- with Sjogren’s syndrome, rheumatoid arthritis, systemic lupus er- tially autoreactive T cells interfere with the normal mechanisms of ithematosus, and Crohn’s disease, among others (2). Lymphopenia peripheral self-tolerance have not been determined. To address may also occur after viral infections, as has been described in the these issues, we have used a well-characterized transgenic murine case of HIV infection. In AIDS patients who undergo highly active system consisting of 3 different mouse lines: InsHA mice express antiretroviral therapy, the frequency of HIV-associated immune the hemagglutinin (HA) of the influenza virus under the control of reconstitution inflammatory syndrome, a phenomenon that shares the rat insulin promoter, driving its expression in the beta cells of many characteristics with autoimmune processes, and rheumatoid the pancreas (23). Clone 4 TCR and HNT TCR transgenics express arthritis and type 1 diabetes, is increased (3, 4). Importantly, the HA-specific MHC class I and class II-restricted TCRs, respectively association between lymphopenia and the exacerbation of anti-self (24, 25). After transfer into InsHA mice, naive Clone 4 CD8ϩ T responses has recently been exploited to augment the responsive- cells recirculate through secondary lymphoid organs, but are unable ness of T lymphocytes against cancer. Specifically, adoptive T cell to reach peripheral tissues and, hence, cannot directly enter in immunotherapy targeting self-tumor antigens has been enhanced contact with pancreatic islets (26, 27). Under these conditions, the by prior lymphodepletion of melanoma patients (5). Studies in murine models have been instrumental in furthering our understanding of the link between lymphopenia and the onset Author contributions: C.L.S., N.T., and J.H. designed research; C.L.S. and S.M. performed of autoimmunity. Indeed, thymectomy in neonatal mice and the research; C.L.S., S.M., N.T., and J.H. analyzed data; and C.L.S., N.T., and J.H. wrote the paper. transfer of low numbers of lymphocytes into irradiated, SCID or The authors declare no conflict of interest. RAGϪ/Ϫ mice result in autoimmune processes (1). This type of This article is a PNAS Direct Submission. studies served to unveil the role of regulatory lymphocytes in Freely available online through the PNAS open access option. peripheral tolerance (6, 7). However, an absence of regulatory T 1To whom correspondence should be addressed. E-mail: [email protected]. cells is not the sole factor triggering autoimmunity (8). Under This article contains supporting information online at www.pnas.org/cgi/content/full/ lymphopenic conditions, the expansion of residual conventional T 0807743105/DCSupplemental. cells, in the apparent absence of antigenic stimulation, is well © 2008 by The National Academy of Sciences of the USA 19414–19419 ͉ PNAS ͉ December 9, 2008 ͉ vol. 105 ͉ no. 49 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0807743105 Downloaded by guest on September 28, 2021 transferred CD8ϩ lymphocytes encounter HA antigen only in the Table 1. CD8؉ and CD4؉ T cells cooperate to induce draining lymph nodes (LNs) of the pancreas cross-presented by autoimmunity under lymphopenic conditions antigen presenting cells (APCs) (26, 27). Cross-presentation is a Number Diabetes Diabetes process by means of which professional APCs, in particular den- Cell transfer* of cells incidence† onset‡ dritic cells, acquire exogenous antigens, transport them to the lymphoid organs, and present them to T cells (28). In InsHA mice, Recipient, irradiated InsHA ϩ the encounter between cross-presenting APCs and HA-specific T Clone 4 CD8 2 ϫ 106 0/11 — ϫ 6 cells results in tolerance, a process that has been termed cross- 3.5 10 0/6 — 5 ϫ 106 1/21 d 12 tolerance, characterized by the abortive activation of the Clone 4 ϫ 6 ϩ 7 10 0/5 — CD8 T cells and their subsequent apoptosis (26). ϫ 6 ϩ 10 10 0/6 — Here, we show that the cotransfer of naive Clone 4 CD8 T cells HNT CD4ϩ 2 ϫ 106 0/10 — ϩ together with naive HNT CD4 T helper cells into lympho-replete 3.5 ϫ 106 1/8 d 12 InsHA mice does not result in autoimmunity. This absence of 5 ϫ 106 0/18 — reactivity is because the CD8ϩ T cells are tolerized through antigen 7 ϫ 106 0/5 — cross-presentation even in the presence of helper cells (29). Nota- 10 ϫ 106 2/10 d 21 ϩ ϩ bly, when InsHA mice are rendered lymphopenic the same poten- Clone 4 CD8 ϩ HNT CD4 2 ϫ 106 ϩ 2 ϫ 106 7/7 d 14 Ϯ 4 ϫ 6 ϩ ϫ 6 Ϯ tially autoreactive CD8ϩ and CD4ϩ T cells differentiate into 3.5 10 3.5 10 13/15 d 14 3 5 ϫ 106 ϩ 5 ϫ 106 14/14 d 11 Ϯ 1 memory-like cells and cooperate to induce autoimmune diabetes ϩ ϩ Clone 4 CD8 ϩ DO11.10 CD4 3.5 ϫ 106 ϩ 3.5 ϫ 106 0/11 — overcoming cross-tolerance. Clone 4 CD8ϩ ϩ InsHA CD4ϩ 3.5 ϫ 106 ϩ 3.5 ϫ 106 0/8 — Recipient, nonirradiated InsHA Results Clone 4 CD8ϩ ϩ HNT CD4ϩ 5 ϫ 106 ϩ 5 ϫ 106 0/8 — Memory-Like CD8؉ T Cells Are Not Sufficient to Induce Autoimmune ϩ ϩ Diabetes Under Lymphopenic Conditions. To assess whether HA- *Purified transgenic CD8 and/or CD4 T cells, as indicated, were injected into specific Clone 4 CD8ϩ T cells undergo lymphopenia-induced either irradiated or nonirradiated InsHA mice. †The onset of autoimmunity was evaluated by measuring blood glucose levels. proliferation, these cells were adoptively transferred into sublethally ϩ Mice were followed over a 1 month period and were considered diabetic when irradiated BALB/c mice.
Load more

Recommended publications
  • George D. Snell
    NATIONAL ACADEMY OF SCIENCES GEORGE DAVIS SNELL 1903–1996 A Biographical Memoir by N. AVRION MITCHISON Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 83 PUBLISHED 2003 BY THE NATIONAL ACADEMIES PRESS WASHINGTON, D.C. GEORGE DAVIS SNELL December 19, 1903–June 6, 1996 BY N. AVRION MITCHISON ENETICIST GEORGE SNELL is known principally for his part G in the discovery of H2, the major histocompatibility complex (MHC) of the mouse and the first known MHC. For this he shared the 1980 Nobel Prize in physiology or medicine. He was elected to the National Academy of Sci- ences in 1970. Most of his life was spent at Bar Harbor, Maine, where he worked in the Jackson Laboratory. George was proud of his New England roots, moral and intellectual. His life was passed in the northeast, apart from brief spells in Texas and the Midwest. He was born in Bradford, Massachusetts, and at the age of 19 went to Dartmouth College, where he obtained his B.S, degree in biology in 1926. He went on to Harvard University, where he obtained his D.Sc. four years later at the Bussey Institu- tion. During his last year he served as an instructor back at Dartmouth, and in the following year served again as an instructor at Brown University. He then obtained a National Research Council Fellowship to work at the University of Texas in the laboratory of H. J. Muller (1931-33) and re- turned there 20 years later to spend a sabbatical year read- ing up on ethics, as mentioned below.
    [Show full text]
  • And STAT4–Dependent IL-33 Receptor Expression Directly Promotes Antiviral Th1 Cell Responses
    T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses Claudia Baumanna,b,1, Weldy V. Bonillac,1, Anja Fröhlicha,b, Caroline Helmstettera,b, Michael Peinea,b, Ahmed N. Hegazyd, Daniel D. Pinschewerc,2,3, and Max Löhninga,b,2,3 aExperimental Immunology, Department of Rheumatology and Clinical Immunology, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany; bGerman Rheumatism Research Center Berlin, 10117 Berlin, Germany; cDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel, Switzerland; and dTranslational Gastroenterology Unit, Nuffield Department of Clinical Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom Edited* by N. Avrion Mitchison, University College London Medical School, London, United Kingdom, and approved February 20, 2015 (received for review September 25, 2014) During infection, the release of damage-associated molecular associated transcription factors T-bet and STAT4 controlled patterns, so-called “alarmins,” orchestrates the immune response. ST2 expression in vivo and in vitro. ST2 deficiency of LCMV- + The alarmin IL-33 plays a role in a wide range of pathologies. Upon specific CD4 T cells resulted in impaired effector Th1 cell release, IL-33 signals through its receptor ST2, which reportedly is differentiation with substantially reduced cell expansion, im- + expressed only on CD4 T cells of the Th2 and regulatory subsets. paired antiviral cytokine production, and little virus-induced Here we show that Th1 effector cells also express ST2 upon differ- T-cell–mediated immunopathology. Thus, IL-33 acts directly + entiation in vitro and in vivo during lymphocytic choriomeningitis on CD4 T cells during infection to enhance antiviral effector virus (LCMV) infection.
    [Show full text]
  • Brian B. Boycott 38
    EDITORIAL ADVISORY COMMITTEE Marina Bentivoglio Duane E. Haines Edward A. Kravitz Louise H. Marshall Aryeh Routtenberg Thomas Woolsey Lawrence Kruger (Chairperson) The History of Neuroscience in Autobiography VOLUME 3 Edited by Larry R. Squire ACADEMIC PRESS A Harcourt Science and Technology Company San Diego San Francisco New York Boston London Sydney Tokyo This book is printed on acid-free paper. (~ Copyright © 2001 by The Society for Neuroscience All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Requests for permission to make copies of any part of the work should be mailed to: Permissions Department, Harcourt Inc., 6277 Sea Harbor Drive, Orlando, Florida 32887-6777 Academic Press A Harcourt Science and Technology Company 525 B Street, Suite 1900, San Diego, California 92101-4495, USA http://www.academicpress.com Academic Press Harcourt Place, 32 Jamestown Road, London NW1 7BY, UK http://www.academicpress.com Library of Congress Catalog Card Number: 96-070950 International Standard Book Number: 0-12-660305-7 PRINTED IN THE UNITED STATES OF AMERICA 01 02 03 04 05 06 SB 9 8 7 6 5 4 3 2 1 Contents Morris H. Aprison 2 Brian B. Boycott 38 Vernon B. Brooks 76 Pierre Buser 118 Hsiang-Tung Chang 144 Augusto Claudio Guillermo Cuello 168 Robert W. Doty 214 Bernice Grafstein 246 Ainsley Iggo 284 Jennifer S. Lund 312 Patrick L. McGeer and Edith Graef McGeer 330 Edward R.
    [Show full text]
  • Immune Privilege As an Intrinsic CNS Property: Astrocytes Protect the CNS Against T-Cell-Mediated Neuroinflammation
    Hindawi Publishing Corporation Mediators of Inflammation Volume 2013, Article ID 320519, 11 pages http://dx.doi.org/10.1155/2013/320519 Review Article Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation Ulrike Gimsa,1 N. Avrion Mitchison,2 and Monika C. Brunner-Weinzierl3 1 Institute of Behavioural Physiology, Leibniz Institute for Farm Animal Biology, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, Germany 2 Division of Infection and Immunity, University College London, Cruciform Building, Gower Street, London WC1 6BT, UK 3 Experimental Pediatrics, University Hospital, Otto-von-Guericke University Magdeburg, Leipziger Straße 44, 39120Magdeburg,Germany Correspondence should be addressed to Monika C. Brunner-Weinzierl; [email protected] Received 21 February 2013; Accepted 9 July 2013 Academic Editor: Jonathan P. Godbout Copyright © 2013 Ulrike Gimsa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Astrocytes have many functions in the central nervous system (CNS). They support differentiation and homeostasis of neurons and influence synaptic activity. They are responsible for formation of the blood-brain barrier (BBB) and make up the glia limitans. Here, we review their contribution to neuroimmune interactions and in particular to those induced by the invasion of activated T cells. We discuss the mechanisms by which astrocytes regulate pro- and anti-inflammatory aspects of T-cell responses within the CNS. Depending on the microenvironment, they may become potent antigen-presenting cells for T cells and they may contribute to inflammatory processes.
    [Show full text]
  • NIMR) C.1960–C.2000
    TECHNOLOGY, TECHNIQUES, AND TECHNICIANS AT THE NATIONAL INSTITUTE FOR MEDICAL RESEARCH (NIMR) c.1960–c.2000 The transcript of a Witness Seminar held by the History of Modern Biomedicine Research Group, Queen Mary University of London, on 17 June 2014 Edited by C Overy and E M Tansey Volume 59 2016 ©The Trustee of the Wellcome Trust, London, 2016 First published by Queen Mary University of London, 2016 The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 1 91019 5161 All volumes are freely available online at www.histmodbiomed.org Please cite as: Overy C, Tansey E M. (eds) (2016) Technology, Techniques, and Technicians at the National Institute for Medical Research (NIMR) c.1960–c.2000. Wellcome Witnesses to Contemporary Medicine, vol. 59. London: Queen Mary University of London. CONTENTS What is a Witness Seminar? v Acknowledgements E M Tansey and C Overy vii Illustrations and credits ix Abbreviations xv Introduction Jim Smith xvii Transcript Edited by C Overy and E M Tansey 1 Appendix 1 Floor plans of the NIMR at Holly Hill 125 Appendix 2 The fraction collector 127 Appendix 3 A history of the chemistry laboratory: Form and function Peter J T Morris 129 Appendix 4 Computers at the NIMR Steven White 145 Appendix 5 The planimeter Anthony S Travis 149 Appendix 6 The first decade at the NIMR, Mill Hill: The instruments that revolutionized analytical chemistry Anthony S Travis 151 Appendix 7 Apparatus used to prepare cell walls Ian Mathison 171 Appendix 8 References by Sutherland et al.
    [Show full text]
  • Brigitte Askonas 1923–2013
    ObiTuarY Brigitte Askonas 1923–2013 Emil R Unanue Brigitte Askonas, known to her friends as ‘Ita’, passed away peacefully pass that unique trait on to her trainees. I had a great experience with on 9 January 2013 after a brief illness with cancer, a few months short her, and my time spent under her mentorship changed my career. She of her 90th birthday. Ita lived a long, full and enjoyable life and made was incredibly unselfish, and when I formed my own laboratory after major contributions to the understanding of the immune system. She leaving Mill Hill, she allowed me to continue the work that she and made countless friends in and out of science and was highly influ- I had started. We kept in touch over the years, and she continued to ential in molding the careers of many. She was universally loved and follow my work. Ita was always there to provide me with her objective respected and, in return, she genuinely cared deeply for her many opinions, criticisms and suggestions on the work. She would let me friends. Her curiosity and enthusiasm for biology, and her keen and know when she disagreed with me. I came to value these interactions critical eye for scientific excellence, never dwindled one bit over her greatly and I respected the time and effort she spent helping not only long and illustrious career. me but also others. The reason I have emphasized my experiences Ita thoroughly relished her entire career that spanned her entrance in her laboratory and afterward and her influence on my future is to into the field of immunology in the mid-1950s (when the cellular make the point that such experiences were not restricted to me.
    [Show full text]
  • Cell Death in the Immune System
    CELL DEATH IN THE IMMUNE SYSTEM Tessa Crompton Imperial Cancer Research Fund Tumour Immunology Unit Department of Biology University College London A thesis submitted for the degree of PhD University of London 1990 1 ProQuest Number: 10609764 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10609764 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENTS I would like to thank the members of the Biology department, Medawar building, for discussions and assistance, in particular Avrion Mitchison, Benny Chain, Nigel Pringle and Liz Thompson. Above all, I would like to thank Martin Raff for his help and support. I thank Bob Miller for advice on electron microscopy, Peter Karran for advice on DNA-repair enzyme assays, and Andrew Wyllie for helpful discussions. I thank Martin Raff and Avrion Mitchison for critical reading of this manuscript. 2 ABSTRACT A distinction based on morphological criteria has been made between two forms of mammalian cell death: necrosis, which is mediated by agents external to the cell, and apoptosis, which is believed to be the result of the triggering of an active suicide mechanism in a cell that dies as a result of a physiological, developmentally-regulated process.
    [Show full text]
  • Fmedsci., FUCL CURRICULUM VITAE Professor Sir David Lane Is
    Professor Sir David Lane FRS, FRSE, FRCPath., FRCS (Edinburgh), FmedSci., FUCL CURRICULUM VITAE Professor Sir David Lane is the Director of the Cancer Research UK Transformation Research Group at the University of Dundee, where he leads research teams studying Human Tumour suppressor gene function. He is also Chief Scientist of Agency for Science, Technology and Research (A*STAR). Sir David completed undergraduate and postgraduate degrees at University College London where he studied auto- immunity under the supervision of Avrion Mitchison. He carried out Post Doctoral Research first at the Imperial Cancer Research Fund in London with Lionel Crawford and then at the Cold Spring Harbor Labs in New York with Jo Sambrook. On returning to the UK, Sir David set up his own laboratory with CRC funding at Imperial College, London, then moving to the ICRF laboratories at Clare Hall before moving in 1990 to Dundee to help establish the CRC laboratories there. Sir David has published more than 350 research articles that have been citied over 39,000 times and is internationally recognised for his original discovery of the p53 protein SV40 T antigen complex and for his many subsequent contributions to the p53 field. The p53 gene is the most frequently altered gene in human cancer with more than half of all cancers having mutant p53. He is co-author with Ed Harlow of the most successful practical guide to the use of immunochemical methods. The "Antibodies" manual has sold over 40,000 copies. Sir David is a member of EMBO, and a Fellow of the Royal Society, the UK's premier Academy.
    [Show full text]
  • The Autoimmune Tautology: from Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes
    Autoimmune Diseases The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes Guest Editors: Juan-Manuel Anaya, Adriana Rojas-Villarraga, and Mario García-Carrasco The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes Autoimmune Diseases The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes Guest Editors: Juan-Manuel Anaya, Adriana Rojas-Villarraga, and Mario Garc´ıa-Carrasco Copyright © 2012 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “Autoimmune Diseases.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is prop- erly cited. Editorial Board Corrado Betterle, Italy Evelyn Hess, USA Markus Reindl, Austria Maria Bokarewa, Sweden Stephen Holdsworth, Australia P. Santamaria, Canada Nalini S. Bora, USA Hiroshi Ikegami, Japan Giovanni Savettieri, Italy D. N. Bourdette, USA Francesco Indiveri, Italy Jin-Xiong She, USA Ricard Cervera, Spain P. L. Invernizzi, Italy Animesh A. Sinha, USA Edward K. L. Chan, USA Annegret Kuhn, Germany Jan Storek, Canada M. Cutolo, Italy I. R. Mackay, Australia Alexander J. Szalai, USA George N. Dalekos, Greece Rizgar Mageed, UK Ronald Tuma, USA Thomas Dorner,¨ Germany Grant Morahan, Australia Frode Vartdal, Norway Sudhir Gupta, USA Kamal D. Moudgil, USA Edmond J. Yunis, USA Martin Herrmann, Germany Andras Perl, USA Contents The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes, Juan-Manuel Anaya, Adriana Rojas-Villarraga, and Mario Garc´ıa-Carrasco Volume 2012, Article ID 297193, 2 pages Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis, Paola Cruz-Tapias, Oscar M.
    [Show full text]
  • Annals of the Rheumatic Diseases 1993; 52: S1-S2 Si
    Annals of the Rheumatic Diseases 1993; 52: S1-S2 Si Annals ofthe RHEUMATIC Ann Rheum Dis: first published as 10.1136/ard.52.Suppl_1.S1 on 1 March 1993. Downloaded from DISEASES Foreword Investigators pondering the cause of inflammatory as agent provocateurs and it is vital that their evolutionary rheumatic diseases have been largely preoccupied with patience is matched by those who bestow research immunology since the discovery of autoantibodies over 30 grants. years ago. The ability to initiate organ specific autoimmune These seemingly contrasting interpretations are not diseases by the experimental presentation of organ specific mutually exclusive. 'Some infectious diseases are autoantigens to the immune system gave a further dangerous to us not because the body fails to defend itself incentive to pursue this theme. An analysis of the major against them but-paradoxically-because it does defend rheumatological journals shows that on average some itself: in a sense, the remedy is the disease'.' As a cogent 10-1 5% ofall articles published over the past 20 years have example, immunodeficiency predisposes to rheumatic a major immunological component, and this takes no disorders, through atypical infections in common variable account of immunological investigations into the hypogammaglobulinaemia and putatively from infections rheumatic diseases appearing in other scienti& journals. in complement deficiency associated with connective tissue Much of this massive body of data has informed us about diseases. Severe forms of immunodeficiency, such as immunopathological mechanisms. For example, it is highly defects in HLA molecule assembly, may well prove to be probable that cytokines synthesised in the rheumatoid gross examples of commoner defects predisposing to synovial membrane make a major contribution to cartilage persistent infections with immunological abnormalities.
    [Show full text]
  • The Royal College of Physicians and Oxford Brookes University Medical Sciences Video Archive MSVA 163
    © Oxford Brookes University 2012 The Royal College of Physicians and Oxford Brookes University Medical Sciences Video Archive MSVA 163 Dame Bridget Ogilvie DBE DSc in interview with Dr Max Blythe Oxford 16 May 1997 Interview One MB Dame Bridget Ogilvie, you were born in March 1938, eighteen months before World War II, in New South Wales on a property where your father was farming sheep. BO Yes, that’s right. Father was quite an enthusiastic but not tremendously successful farmer. MB Yes, I heard tell. A great character though. BO Yes, he was. We had merinos. It was mountainous country, a little bit like the Yorkshire Dales probably, and in those early days the winters were very severe there. The sheep didn’t do too well because of the food under this very poor environment and a lack of certain minerals in the soil, so the wool was very fine because the sheep were half-starving and they were very susceptible to disease. MB The winters were cold? BO Oh yes, very cold. Much colder than here in many ways. MB So, on this station among these gentle undulating uplands, you grew up. How many acres did the station have? BO Well, it was about three thousand acres. It was on the New England tableland, which is about three thousand feet above sea level with a very severe climate in winter, a diurnal fluctuation in temperature from Fahrenheit minus ten or twelve degrees up to sixty degrees during the day, so it’s a very severe environment for anything that wants to grow in the winter.
    [Show full text]
  • Clinical and Experimental Studies on the Cellular Mediators of Corneal Allograft Rejection
    Clinical and experimental studies on the cellular mediators of corneal allograft rejection by Thomas Henry Flynn A thesis submitted to University College London for the degree of Doctor of Philosophy Department of Ocular Immunology UCL Institute of Ophthalmology Bath Street London May 2010 1 STATEMENT OF ORIGINALITY I, Tom Flynn, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis 2 ACKNOWLEDGEMENTS The work described in this thesis could not have been done without the support of a number of people and organisations and it is a pleasure to thank them now. I would like to thank my supervisors Mr Frank Larkin and Professor Santa J Ono for offering me the opportunity to undertake this work and for their guidance and support throughout my studentship. I am grateful to the special trustees of Moorfields Eye Hospital, Pfizer, The Irish College of Ophthalmologists and Fight for Sight for supporting my research. I would like to thank all of my colleagues in the laboratory but especially Dr Masaharu Ohbayashi for his help with immunohistochemistry and the mouse model of allergic conjunctivitis and Professor Avrion Mitchison for his friendship and guidance during my project. I would like to express my gratitude to my parents for all their support and encouragement over the years. I owe my deepest gratitude to my wife Joanne for her unwavering and unconditional support and patience throughout this project. I dedicate this thesis to her and to our son David.
    [Show full text]